1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Erythropoietin (EPO) 1.2.3 Human Growth Hormone (HGH) 1.2.4 Granulocyte- Colony Stimulating Factor (G-CSF) 1.2.5 Monoclonal Antibody (mAb) 1.2.6 Insulin 1.2.7 Interferon (IFN) 1.2.8 Others 1.3 Market by Application 1.3.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Anti-Cancer 1.3.3 Anti-Inflammatory/Autoimmune 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Perspective (2016-2027) 2.2 Monoclonal antibodies (mAbs) Biosimilars Growth Trends by Regions 2.2.1 Monoclonal antibodies (mAbs) Biosimilars Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Monoclonal antibodies (mAbs) Biosimilars Historic Market Share by Regions (2016-2021) 2.2.3 Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Regions (2022-2027) 2.3 Monoclonal antibodies (mAbs) Biosimilars Industry Dynamic 2.3.1 Monoclonal antibodies (mAbs) Biosimilars Market Trends 2.3.2 Monoclonal antibodies (mAbs) Biosimilars Market Drivers 2.3.3 Monoclonal antibodies (mAbs) Biosimilars Market Challenges 2.3.4 Monoclonal antibodies (mAbs) Biosimilars Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Monoclonal antibodies (mAbs) Biosimilars Players by Revenue 3.1.1 Global Top Monoclonal antibodies (mAbs) Biosimilars Players by Revenue (2016-2021) 3.1.2 Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Players (2016-2021) 3.2 Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Monoclonal antibodies (mAbs) Biosimilars Revenue 3.4 Global Monoclonal antibodies (mAbs) Biosimilars Market Concentration Ratio 3.4.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Monoclonal antibodies (mAbs) Biosimilars Revenue in 2020 3.5 Monoclonal antibodies (mAbs) Biosimilars Key Players Head office and Area Served 3.6 Key Players Monoclonal antibodies (mAbs) Biosimilars Product Solution and Service 3.7 Date of Enter into Monoclonal antibodies (mAbs) Biosimilars Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Monoclonal antibodies (mAbs) Biosimilars Breakdown Data by Type 4.1 Global Monoclonal antibodies (mAbs) Biosimilars Historic Market Size by Type (2016-2021) 4.2 Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Type (2022-2027) 5 Monoclonal antibodies (mAbs) Biosimilars Breakdown Data by Application 5.1 Global Monoclonal antibodies (mAbs) Biosimilars Historic Market Size by Application (2016-2021) 5.2 Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Monoclonal antibodies (mAbs) Biosimilars Market Size (2016-2027) 6.2 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type 6.2.1 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2021) 6.2.2 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2022-2027) 6.2.3 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2027) 6.3 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application 6.3.1 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2016-2021) 6.3.2 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2022-2027) 6.3.3 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2016-2027) 6.4 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country 6.4.1 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2016-2021) 6.4.2 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size (2016-2027) 7.2 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Type 7.2.1 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2021) 7.2.2 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2022-2027) 7.2.3 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2027) 7.3 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Application 7.3.1 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2016-2021) 7.3.2 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2022-2027) 7.3.3 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2016-2027) 7.4 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Country 7.4.1 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2016-2021) 7.4.2 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size (2016-2027) 8.2 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Type 8.2.1 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2027) 8.3 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Application 8.3.1 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2016-2027) 8.4 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Region 8.4.1 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size (2016-2027) 9.2 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type 9.2.1 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2021) 9.2.2 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2022-2027) 9.2.3 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2027) 9.3 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application 9.3.1 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2016-2021) 9.3.2 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2022-2027) 9.3.3 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2016-2027) 9.4 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country 9.4.1 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2016-2021) 9.4.2 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size (2016-2027) 10.2 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Type 10.2.1 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2027) 10.3 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Application 10.3.1 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2016-2027) 10.4 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Country 10.4.1 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Biocon 11.1.1 Biocon Company Details 11.1.2 Biocon Business Overview 11.1.3 Biocon Monoclonal antibodies (mAbs) Biosimilars Introduction 11.1.4 Biocon Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) 11.1.5 Biocon Recent Development 11.2 Celltrion 11.2.1 Celltrion Company Details 11.2.2 Celltrion Business Overview 11.2.3 Celltrion Monoclonal antibodies (mAbs) Biosimilars Introduction 11.2.4 Celltrion Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) 11.2.5 Celltrion Recent Development 11.3 Dr. Reddy's Laboratories 11.3.1 Dr. Reddy's Laboratories Company Details 11.3.2 Dr. Reddy's Laboratories Business Overview 11.3.3 Dr. Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Introduction 11.3.4 Dr. Reddy's Laboratories Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) 11.3.5 Dr. Reddy's Laboratories Recent Development 11.4 Hospira 11.4.1 Hospira Company Details 11.4.2 Hospira Business Overview 11.4.3 Hospira Monoclonal antibodies (mAbs) Biosimilars Introduction 11.4.4 Hospira Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) 11.4.5 Hospira Recent Development 11.5 3SBio 11.5.1 3SBio Company Details 11.5.2 3SBio Business Overview 11.5.3 3SBio Monoclonal antibodies (mAbs) Biosimilars Introduction 11.5.4 3SBio Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) 11.5.5 3SBio Recent Development 11.6 Accord Healthcare 11.6.1 Accord Healthcare Company Details 11.6.2 Accord Healthcare Business Overview 11.6.3 Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Introduction 11.6.4 Accord Healthcare Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) 11.6.5 Accord Healthcare Recent Development 11.7 AET Biotech 11.7.1 AET Biotech Company Details 11.7.2 AET Biotech Business Overview 11.7.3 AET Biotech Monoclonal antibodies (mAbs) Biosimilars Introduction 11.7.4 AET Biotech Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) 11.7.5 AET Biotech Recent Development 11.8 Allergan 11.8.1 Allergan Company Details 11.8.2 Allergan Business Overview 11.8.3 Allergan Monoclonal antibodies (mAbs) Biosimilars Introduction 11.8.4 Allergan Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) 11.8.5 Allergan Recent Development 11.9 Amega Biotech 11.9.1 Amega Biotech Company Details 11.9.2 Amega Biotech Business Overview 11.9.3 Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Introduction 11.9.4 Amega Biotech Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) 11.9.5 Amega Biotech Recent Development 11.10 Others 11.10.1 Others Company Details 11.10.2 Others Business Overview 11.10.3 Others Monoclonal antibodies (mAbs) Biosimilars Introduction 11.10.4 Others Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) 11.10.5 Others Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Monoclonal antibodies (mAbs) Biosimilars Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Erythropoietin (EPO) Table 3. Key Players of Human Growth Hormone (HGH) Table 4. Key Players of Granulocyte- Colony Stimulating Factor (G-CSF) Table 5. Key Players of Monoclonal Antibody (mAb) Table 6. Key Players of Insulin Table 7. Key Players of Interferon (IFN) Table 8. Key Players of Others Table 9. Global Monoclonal antibodies (mAbs) Biosimilars Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 11. Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Regions (2016-2021) & (US$ Million) Table 12. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Regions (2016-2021) Table 13. Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 14. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Regions (2022-2027) Table 15. Monoclonal antibodies (mAbs) Biosimilars Market Trends Table 16. Monoclonal antibodies (mAbs) Biosimilars Market Drivers Table 17. Monoclonal antibodies (mAbs) Biosimilars Market Challenges Table 18. Monoclonal antibodies (mAbs) Biosimilars Market Restraints Table 19. Global Monoclonal antibodies (mAbs) Biosimilars Revenue by Players (2016-2021) & (US$ Million) Table 20. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Players (2016-2021) Table 21. Global Top Monoclonal antibodies (mAbs) Biosimilars Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal antibodies (mAbs) Biosimilars as of 2020) Table 22. Ranking of Global Top Monoclonal antibodies (mAbs) Biosimilars Companies by Revenue (US$ Million) in 2020 Table 23. Global 5 Largest Players Market Share by Monoclonal antibodies (mAbs) Biosimilars Revenue (CR5 and HHI) & (2016-2021) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Monoclonal antibodies (mAbs) Biosimilars Product Solution and Service Table 26. Date of Enter into Monoclonal antibodies (mAbs) Biosimilars Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2021) (US$ Million) Table 29. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Type (2016-2021) Table 30. Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Type (2022-2027) (US$ Million) Table 31. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Type (2022-2027) & (US$ Million) Table 32. Global Monoclonal antibodies (mAbs) Biosimilars Market Size Share by Application (2016-2021) & (US$ Million) Table 33. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Application (2016-2021) Table 34. Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Application (2022-2027) (US$ Million) Table 35. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Application (2022-2027) & (US$ Million) Table 36. North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2021) (US$ Million) Table 37. North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2022-2027) & (US$ Million) Table 38. North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2016-2021) (US$ Million) Table 39. North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2022-2027) & (US$ Million) Table 40. North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2016-2021) & (US$ Million) Table 41. North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2022-2027) & (US$ Million) Table 42. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2021) (US$ Million) Table 43. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2022-2027) & (US$ Million) Table 44. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2016-2021) (US$ Million) Table 45. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2022-2027) & (US$ Million) Table 46. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2016-2021) & (US$ Million) Table 47. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2022-2027) & (US$ Million) Table 48. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2021) (US$ Million) Table 49. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2022-2027) & (US$ Million) Table 50. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2016-2021) (US$ Million) Table 51. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2022-2027) & (US$ Million) Table 52. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Region (2016-2021) & (US$ Million) Table 53. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Region (2022-2027) & (US$ Million) Table 54. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2021) (US$ Million) Table 55. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2022-2027) & (US$ Million) Table 56. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2016-2021) (US$ Million) Table 57. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2022-2027) & (US$ Million) Table 58. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2016-2021) & (US$ Million) Table 59. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2022-2027) & (US$ Million) Table 60. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2016-2021) (US$ Million) Table 61. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2022-2027) & (US$ Million) Table 62. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2016-2021) (US$ Million) Table 63. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2022-2027) & (US$ Million) Table 64. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2016-2021) & (US$ Million) Table 65. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2022-2027) & (US$ Million) Table 66. Biocon Company Details Table 67. Biocon Business Overview Table 68. Biocon Monoclonal antibodies (mAbs) Biosimilars Product Table 69. Biocon Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) & (US$ Million) Table 70. Biocon Recent Development Table 71. Celltrion Company Details Table 72. Celltrion Business Overview Table 73. Celltrion Monoclonal antibodies (mAbs) Biosimilars Product Table 74. Celltrion Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) & (US$ Million) Table 75. Celltrion Recent Development Table 76. Dr. Reddy's Laboratories Company Details Table 77. Dr. Reddy's Laboratories Business Overview Table 78. Dr. Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Product Table 79. Dr. Reddy's Laboratories Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) & (US$ Million) Table 80. Dr. Reddy's Laboratories Recent Development Table 81. Hospira Company Details Table 82. Hospira Business Overview Table 83. Hospira Monoclonal antibodies (mAbs) Biosimilars Product Table 84. Hospira Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) & (US$ Million) Table 85. Hospira Recent Development Table 86. 3SBio Company Details Table 87. 3SBio Business Overview Table 88. 3SBio Monoclonal antibodies (mAbs) Biosimilars Product Table 89. 3SBio Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) & (US$ Million) Table 90. 3SBio Recent Development Table 91. Accord Healthcare Company Details Table 92. Accord Healthcare Business Overview Table 93. Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Product Table 94. Accord Healthcare Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) & (US$ Million) Table 95. Accord Healthcare Recent Development Table 96. AET Biotech Company Details Table 97. AET Biotech Business Overview Table 98. AET Biotech Monoclonal antibodies (mAbs) Biosimilars Product Table 99. AET Biotech Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) & (US$ Million) Table 100. AET Biotech Recent Development Table 101. Allergan Company Details Table 102. Allergan Business Overview Table 103. Allergan Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) & (US$ Million) Table 104. Allergan Recent Development Table 105. Amega Biotech Company Details Table 106. Amega Biotech Business Overview Table 107. Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Product Table 108. Amega Biotech Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) & (US$ Million) Table 109. Amega Biotech Recent Development Table 110. Others Company Details Table 111. Others Business Overview Table 112. Others Monoclonal antibodies (mAbs) Biosimilars Product Table 113. Others Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) & (US$ Million) Table 114. Others Recent Development Table 115. Research Programs/Design for This Report Table 116. Key Data Information from Secondary Sources Table 117. Key Data Information from Primary Sources List of Figures Figure 1. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Type: 2020 VS 2027 Figure 2. Erythropoietin (EPO) Features Figure 3. Human Growth Hormone (HGH) Features Figure 4. Granulocyte- Colony Stimulating Factor (G-CSF) Features Figure 5. Monoclonal Antibody (mAb) Features Figure 6. Insulin Features Figure 7. Interferon (IFN) Features Figure 8. Others Features Figure 9. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Application: 2020 VS 2027 Figure 10. Anti-Cancer Case Studies Figure 11. Anti-Inflammatory/Autoimmune Case Studies Figure 12. Monoclonal antibodies (mAbs) Biosimilars Report Years Considered Figure 13. Global Monoclonal antibodies (mAbs) Biosimilars Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 14. Global Monoclonal antibodies (mAbs) Biosimilars Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Regions: 2020 VS 2027 Figure 16. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Regions (2022-2027) Figure 17. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Players in 2020 Figure 18. Global Top Monoclonal antibodies (mAbs) Biosimilars Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal antibodies (mAbs) Biosimilars as of 2020 Figure 19. The Top 10 and 5 Players Market Share by Monoclonal antibodies (mAbs) Biosimilars Revenue in 2020 Figure 20. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Type (2016-2021) Figure 21. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Type (2022-2027) Figure 22. North America Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. North America Monoclonal antibodies (mAbs) Biosimilars Market Share by Type (2016-2027) Figure 24. North America Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2016-2027) Figure 25. North America Monoclonal antibodies (mAbs) Biosimilars Market Share by Country (2016-2027) Figure 26. United States Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Canada Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Monoclonal antibodies (mAbs) Biosimilars Market Share by Type (2016-2027) Figure 30. Europe Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2016-2027) Figure 31. Europe Monoclonal antibodies (mAbs) Biosimilars Market Share by Country (2016-2027) Figure 32. Germany Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. France Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. U.K. Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Italy Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Russia Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Nordic Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Share by Type (2016-2027) Figure 40. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2016-2027) Figure 41. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Share by Region (2016-2027) Figure 42. China Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Japan Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. South Korea Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. India Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Australia Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Share by Type (2016-2027) Figure 50. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2016-2027) Figure 51. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Share by Country (2016-2027) Figure 52. Mexico Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Brazil Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Share by Type (2016-2027) Figure 56. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2016-2027) Figure 57. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Share by Country (2016-2027) Figure 58. Turkey Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Saudi Arabia Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. UAE Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. Biocon Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) Figure 62. Celltrion Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) Figure 63. Dr. Reddy's Laboratories Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) Figure 64. Hospira Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) Figure 65. 3SBio Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) Figure 66. Accord Healthcare Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) Figure 67. AET Biotech Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) Figure 68. Allergan Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) Figure 69. Amega Biotech Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) Figure 70. Others Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2016-2021) Figure 71. Bottom-up and Top-down Approaches for This Report Figure 72. Data Triangulation Figure 73. Key Executives Interviewed

Biocon Celltrion Dr. Reddy's Laboratories Hospira 3SBio Accord Healthcare AET Biotech Allergan Amega Biotech Others